Mast cells protect mice from mycoplasma pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 2, 2006, Pages 219-225

  Xu, Xiang ^b   Zhang, Dongji ^b   Lyubynska, Natalya ^b   Wolters, Paul J ^b   Killeen, Nigel P ^b   Baluk, Peter ^b   McDonald, Donald M ^b   Hawgood, Samuel ^b   Caughey, George H ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Angiogenesis; Bronchitis; Innate immunity; Lymphangiogenesis; Pneumonia

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

AIRWAY OBSTRUCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY WEIGHT; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; INNATE IMMUNITY; LUNG BURDEN; LUNG EXTRAVASCULAR FLUID; LYMPH NODE; LYMPHANGIOGENESIS; MAST CELL; MORTALITY; MOUSE; MOUSE STRAIN; MYCOPLASMA PNEUMONIA; MYCOPLASMA PULMONIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LUNG; LYMPH NODES; MAST CELLS; MICE; MICE, INBRED C57BL; MYCOPLASMA PULMONIS; ORGAN SIZE; PNEUMONIA, MYCOPLASMA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; TIME FACTORS; VACCINES, INACTIVATED;

EID: 31944437499     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200507-1034OC     Document Type: Article

References (41)

1. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-80.
2. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77.
3. Mallen-St Clair J, Pham CT, Villalta SA, Caughey GH, Wolters PJ. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J Clin Invest 2004;113:628-634.
4. Maurer M, Echtenacher B, Hultner L, Kollias G, Männel DN, Langley KE, Galli SJ. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998;188:2343-2348.
5. Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003;170:2274-2278.
6. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992;258:1957-1959.
7. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, Abraham SN. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003;4:1199-1205.
8. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005;102:6467-6472.
9. Prodeus AP, Zhou XN, Maurer M, Galli SJ, Carroll MC. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997;390:172-175.
10. Gommerman JL, Oh DY, Zhou X, Tedder TF, Maurer M, Galli SJ, Carroll MC. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol 2000;165:6915-6921.
11. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 2001;167:2250-2256.
12. McCurdy JD, Olynych TJ, Maher LH,Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003;170:1625-1629.
13. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004;432:512-516.
14. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728.
15. Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 1994;149:1348-1353.
16. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107:595-601.
17. McDonald DM, Schoeb TR, Lindsey JR. Mycoplasma infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest 1991;87:787-799.
18. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001;24:577-582.
19. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998;62:1094-1156.
20. Baluk P, Raymond WW, Ator E, Coussens LM, McDonald DM, Caughey GH. Matrix metalloproteinase-2 and -9 expression increases in mycoplasma-infected airways but is not required for microvascular remodeling. Am J Physiol Lung Cell Mol Physiol 2004;287:L307-L317.
21. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D. In.ammatory mast cells upregulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999;13:1382-1397.
22. Oh S-W, Pae CI, Lee D-K, Jones F, Chiang GKS, Kim H-O, Moon S-H, Cao B, Ogbu C, Jeong K-W, et al. Tryptase inhibition blocks airway in.ammation in a mouse asthma model. J Immunol 2002;168:1992-2000.
23. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic in.ammation in an asthma model in mice. J Exp Med 2000;192:455-462.
24. Chu HW, Rino JG, Wexler RB, Campbell K, Harbeck RJ, Martin RJ. Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005;289:L125-L133.
25. Xu X, Zhang DJ, Killeen NP, Caughey GH. Mast cells protect mice from lung mycoplasma infection.Am J Respir Crit Care Med 2004;169:A807.
26. W-sh sash mice. Clin Exp Allergy 2005;35:82-88.
27. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005;115:247-257.
28. Cimolai N, Taylor GP, Mah D, Morrison BJ. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol 1992;36:465-478.
29. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521-554.
30. Piboonpocanun S, Chiba H, Mitsuzawa H, Martin W, Murphy RC, Harbeck RJ, Voelker DR. Surfactant protein A binds Mycoplasma pneumoniae with high affinity and attenuates its growth by recognition of disaturated phosphatidylglycerols. J Biol Chem 2005;280:9-17.
31. Akiyama J, Hoffman A, Brown C, Allen L, Edmondson J, Poulain F, Hawgood S. Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 2002;50:993-996.
32. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001;164:S39-S45.
33. Cartner SC, Lindsey JR, Gibbs-Erwin J, Cassell GH, Simecka JW. Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun 1998;66:3485-3491.
34. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167:835-848.
35. Caughey GH. Building a better heparin. Am J Respir Cell Mol Biol 2003;28:129-132.
36. Lever R, Page C. Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness. Pulm Pharmacol Ther 2001;14:249-254.
37. Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K. Enhancement of neutrophil infiltration in histidine decarboxylase-deficient mice. Immunology 2002;107:217-221.
38. Li Y, Karlin A, Loike JD, Silverstein SC. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci USA 2002;99:8289-8294.
39. Hoek KL, Cassell GH, Duffy LB, Atkinson TP. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 2002;109:470-476.
40. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, Jakschik BA, Abraham SN. Mast cell phagocytosis of fimH-expressing enterobacteria. J Immunol 1994;152:1907-1914.
41. Oliveira SH, Lukacs NW. Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm Res 2001;50:168-174.